These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 20180364

  • 1. [Cytomegalovirus primary infection in a patient with Crohn's disease treated with azathioprine and anti-TNF alpha].
    Ben Hriz F, Habbessi H, Maamouri N, Belkahla N, Ouerdiane S, Chouaib S, Ouerghi H, Chaabouni H, Ben Mami N.
    Tunis Med; 2009 Aug; 87(8):545-6. PubMed ID: 20180364
    [No Abstract] [Full Text] [Related]

  • 2. Fatal disseminated cytomegalovirus infection associated with infliximab and 6-mercaptopurine therapy in a child with Crohn disease.
    Pickering O, Weinstein T, Rubin LG.
    Pediatr Infect Dis J; 2009 Jun; 28(6):556. PubMed ID: 19483533
    [No Abstract] [Full Text] [Related]

  • 3. [Therapy of chronic inflammatory bowel diseases. TNF-alpha blocker in Crohn disease: earlier use is rewarding].
    MMW Fortschr Med; 2008 Dec 11; 150(51-52):54-5. PubMed ID: 19156959
    [No Abstract] [Full Text] [Related]

  • 4. Closing fistulas in Crohn's disease--should the accent be on maintenance or safety?
    Fiocchi C.
    N Engl J Med; 2004 Feb 26; 350(9):934-6. PubMed ID: 14985492
    [No Abstract] [Full Text] [Related]

  • 5. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
    Ochsenkühn T, Göke B, Sackmann M.
    Am J Gastroenterol; 2002 Aug 26; 97(8):2022-5. PubMed ID: 12190171
    [Abstract] [Full Text] [Related]

  • 6. Steroid-independent Crohn's disease patients also benefit from combination therapy of infliximab plus azathioprine.
    van den Brande JM, Peppelenbosch MP, Hommes DW.
    Gastroenterology; 2006 Oct 26; 131(4):1362-3. PubMed ID: 17030216
    [No Abstract] [Full Text] [Related]

  • 7. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.
    de Rossi TM, Krauss N, Voll RE, Nägel A, Weidenhiller M, Konturek PC, Hahn EG, Raithel M.
    Digestion; 2008 Oct 26; 78(4):195-200. PubMed ID: 19122456
    [Abstract] [Full Text] [Related]

  • 8. Longstanding Crohn's vulvitis successfully treated with combined anti-TNFα antibody and azathioprine.
    Macdonagh E, Pugh S, Fox R.
    J Obstet Gynaecol; 2013 Jul 26; 33(5):530. PubMed ID: 23815219
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of patients with Crohn's disease and concomitant chronic hepatitis C with a chimeric monoclonal antibody to TNF.
    Holtmann MH, Galle PR, Neurath MF.
    Am J Gastroenterol; 2003 Feb 26; 98(2):504-5. PubMed ID: 12591081
    [No Abstract] [Full Text] [Related]

  • 10. Extra-intestinal Hodgkin's lymphoma in a Crohn's disease patient on long-term azathioprine and infliximab therapy.
    Dahhan T, Al Kahtani K, Bakshi N, Abouzied ME, Helmy A.
    Trop Gastroenterol; 2010 Feb 26; 31(1):51-3. PubMed ID: 20860231
    [No Abstract] [Full Text] [Related]

  • 11. Early postoperative recurrence of severe Crohn's disease, with colonic involvement and associated human cytomegalovirus infection, treated with oral valganciclovir and adalimumab.
    Sinagra E, Renna S, Mocciaro F, Olivo M, Cottone M, Orlando A.
    Inflamm Bowel Dis; 2011 Jun 26; 17(6):E43-4. PubMed ID: 21438099
    [No Abstract] [Full Text] [Related]

  • 12. [Top-down versus Step-Up: new strategies in the treatment of Crohn's disease].
    Meier J, Sturm A.
    Z Gastroenterol; 2009 Feb 26; 47(2):240-2. PubMed ID: 19197829
    [No Abstract] [Full Text] [Related]

  • 13. High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease.
    Martínez-Borra J, López-Larrea C, González S, Fuentes D, Dieguez A, Deschamps EM, Pérez-Pariente JM, López-Vázquez A, de Francisco R, Rodrigo L.
    Am J Gastroenterol; 2002 Sep 26; 97(9):2350-6. PubMed ID: 12358255
    [Abstract] [Full Text] [Related]

  • 14. [Miliary tuberculosis in a patient with Crohn's disease].
    Ferrer I, Maroto N, Montón C, Villagrasa R, López A, Clofent J, Hinojosa J.
    Gastroenterol Hepatol; 2011 Sep 26; 34(7):511-3. PubMed ID: 21737181
    [No Abstract] [Full Text] [Related]

  • 15. Prediction of response to infliximab in Crohn's disease.
    Chaudhary R, Ghosh S.
    Dig Liver Dis; 2005 Aug 26; 37(8):559-63. PubMed ID: 15893967
    [No Abstract] [Full Text] [Related]

  • 16. Cytomegalovirus colitis complicating ulcerative colitis treated with adalimumab.
    Charles P, Ackermann F, Burdy G, Blétry O, Leport J, Kahn JE.
    Scand J Gastroenterol; 2010 Apr 26; 45(4):509-10. PubMed ID: 20095878
    [No Abstract] [Full Text] [Related]

  • 17. Infliximab treatment induces levels of the active azathioprine metabolite TGTP in Crohn's disease.
    Teichgräber U, Atreya I, Atreya R, Schwab M, Neurath MF.
    Inflamm Bowel Dis; 2013 Apr 26; 19(4):E54-5. PubMed ID: 22532373
    [No Abstract] [Full Text] [Related]

  • 18. Management of Crohn's disease--a practical approach.
    Knutson D, Greenberg G, Cronau H.
    Am Fam Physician; 2003 Aug 15; 68(4):707-14. PubMed ID: 12952387
    [Abstract] [Full Text] [Related]

  • 19. [Hodgkin's lymphoma in a patient with Crohn's disease treated with azathioprine and antibodies anti tumor necrosis factor α].
    Sagüés M, Navarro JT, Ribera JM, Millá F.
    Med Clin (Barc); 2012 Apr 07; 138(8):366-7. PubMed ID: 21752407
    [No Abstract] [Full Text] [Related]

  • 20. Appropriateness of therapy for fistulizing Crohn's disease: findings from a national inflammatory bowel disease cohort.
    Pittet V, Juillerat P, Michetti P, Vader JP, Burnand B, Rogler G, Beglinger C, Seibold F, Mottet C, Felley C, Gonvers JJ, Froehlich F, Swiss IBD Cohort Study Group.
    Aliment Pharmacol Ther; 2010 Oct 07; 32(8):1007-16. PubMed ID: 20937046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.